USFDA Issues 11 Observations After Granules India Facility Inspection
Granules India said the USFDA concluded a cGMP inspection of its finished dosage facility in Gagillapur, Hyderabad, issuing a Form FDA 483 with 11 observations.
Related stories
Nasdaq Issues Delisting Determination for Parabolic Technologies
Nasdaq issued a Staff Delisting Determination after Parabolic Technologies failed to meet the $1.00 minimum bid price requirement. Prior reverse stock splits make the company ineli
H impact | REGULATION | Oct 30, 2026, 08:13 PM UTC
US Approve Patriot Missile Sale to Ukraine
The United States approved the sale of Patriot missiles to Ukraine.
M impact | REGULATION | Oct 30, 2026, 07:42 PM UTC
Mexico Finance Minister Says Deficit Likely to Reach 4.1% of GDP Target
Mexico's finance minister said the September deficit was 2.6% of GDP and is likely to reach the 4.1% target.
M impact | REGULATION | Oct 30, 2026, 07:23 PM UTC
US Approves Possible $2.1 Billion Patriot Missile Sale to Ukraine
The US State Department approved a possible $2.1 billion Patriot missile sale to Ukraine.
M impact | REGULATION | Oct 30, 2026, 07:01 PM UTC
US Sanctions Former Police Chief Accused of War Crimes by ICC
The United States sanctioned a former police chief accused of war crimes by the International Criminal Court.
M impact | REGULATION | Oct 30, 2026, 06:35 PM UTC
US reportedly extends sanctions relief for Serbia’s NIS through Dec. 11
Reuters reports that the United States extended the Serbian oil company NIS’s exemption from sanctions through Dec. 11.
M impact | REGULATION | Oct 30, 2026, 05:59 PM UTC